Shayanti Mukherjee

Dr. Shayanti Mukherjee

The Ritchie Centre, Hudson Institute of Medical Research, Clayton, Australia
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2010 in Journal of The Royal Society Interface
Verified
Journal Article
Closed access
RRRajeswari Ravichandran
Rajeswari Ravichandran
SSSubramanian Sundarrajan
Subramanian Sundarrajan
VRVenugopal Jayarama Reddy
Venugopal Jayarama Reddy
Shayanti MukherjeeShayanti Mukherjee
Shayanti Mukherjee
Seeram RamakrishnaSeeram Ramakrishna
Seeram Ramakrishna
Conducting polymers (CPs) have attracted much interest as suitable matrices of biomolecules and have been used to enhance the stability, speed and sensitivity of various biomedical devices. Moreover, CPs are inexpensive, easy to synthesize and versatile because their properties can be readily modulated by (i) surface functionalization techniques and (ii) the use of a wide range of molecules that can be entrapped or used as dopants. This paper discusses the various surface modifications of the CP that can be employed in order to impart physico-chemical and biological guidance cues that promote cell adhesion/proliferation at the polymer–tissue interface. This ability of the CP to induce various cellular mechanisms widens its applications in medical fields and bioengineering.

1 January 2009 in Cytotherapy
Verified
Journal Article
Closed access
PDF file
JKJyoti Kode
Jyoti Kode
Shayanti MukherjeeShayanti Mukherjee
Shayanti Mukherjee
MJMugdha V. Joglekar
Mugdha V. Joglekar
AHAnandwardhan A. Hardikar
Anandwardhan A. Hardikar
Mesenchymal stem cells (MSC) are multipotent cells that differentiate into osteoblasts, myocytes, chondrocytes and adipocytes as well as insulin-producing cells. The mechanism underlying their in vivo differentiation is not clear and is thought to be caused by spontaneous cell fusion or factors present in the microenvironment. However, their ease of isolation, high ‘ex-vivo’ expansion potential and ability to differentiate into multiple lineages make them attractive tools for potential use in cell therapy. MSC have been isolated from several tissues, including bone/bone marrow, fat, Wharton's jelly, umbilical cord blood, placenta and pancreas. The ‘immunosuppressive’ property of human MSC makes them an important candidate for cellular therapy in allogeneic settings. Use of allogeneic MSC for repair of large defects may be an alternative to autologous and allogeneic tissue-grafting procedures. An allogeneic approach would enable MSC to be isolated from any donor, expanded and cryopreserved, providing a readily available source of progenitors for cell replacement therapy. Their immunomodulatory properties have raised the possibility of establishing allogeneic MSC banks for tissue regeneration. These facts are strongly reflected in the current exponential growth in stem cell research in the pharmaceutical and biotechnology communities. Current knowledge regarding the immunobiology and clinical application of MSC needs to be strengthened further to establish MSC as a safe and effective therapeutic tool in regenerative medicine. This paper discusses human MSC with particular reference to the expression of their surface markers, their role as immunomodulators and their multilineage differentiation potential and possible use in tissue regeneration and repair.

1 January 2012 in Biomaterials
Verified
Journal Article
Closed access
RRRajeswari Ravichandran
Rajeswari Ravichandran
VRVenugopal Jayarama Reddy
Venugopal Jayarama Reddy
SSSubramanian Sundarrajan
Subramanian Sundarrajan
Shayanti MukherjeeShayanti Mukherjee
Shayanti Mukherjee
SRSeeram Ramakrishna
Seeram Ramakrishna

13 April 2011 in Journal of The Royal Society Interface
Verified
Journal Article
Open access
VRVenugopal Jayarama Reddy
Venugopal Jayarama Reddy
MPMolamma P. Prabhakaran
Molamma P. Prabhakaran
Shayanti MukherjeeShayanti Mukherjee
Shayanti Mukherjee
RRRajeswari Ravichandran
Rajeswari Ravichandran
KDKai Dan
Kai Dan
Seeram RamakrishnaSeeram Ramakrishna
Seeram Ramakrishna
World Health Organization estimated that heart failure initiated by coronary artery disease and myocardial infarction (MI) leads to 29 per cent of deaths worldwide. Heart failure is one of the leading causes of death in industrialized countries and is expected to become a global epidemic within the twenty-first century. MI, the main cause of heart failure, leads to a loss of cardiac tissue impairment of left ventricular function. The damaged left ventricle undergoes progressive ‘remodelling’ and chamber dilation, with myocyte slippage and fibroblast proliferation. Repair of diseased myocardium with in vitro-engineered cardiac muscle patch/injectable biopolymers with cells may become a viable option for heart failure patients. These events reflect an apparent lack of effective intrinsic mechanism for myocardial repair and regeneration. Motivated by the desire to develop minimally invasive procedures, the last 10 years observed growing efforts to develop injectable biomaterials with and without cells to treat cardiac failure. Biomaterials evaluated include alginate, fibrin, collagen, chitosan, self-assembling peptides, biopolymers and a range of synthetic hydrogels. The ultimate goal in therapeutic cardiac tissue engineering is to generate biocompatible, non-immunogenic heart muscle with morphological and functional properties similar to natural myocardium to repair MI. This review summarizes the properties of biomaterial substrates having sufficient mechanical stability, which stimulates the native collagen fibril structure for differentiating pluripotent stem cells and mesenchymal stem cells into cardiomyocytes for cardiac tissue engineering.

25 January 2012 in Macromolecular Bioscience
Verified
Journal Article
Closed access
PDF file
RRRajeswari Ravichandran
Rajeswari Ravichandran
SSSubramanian Sundarrajan
Subramanian Sundarrajan
VRVenugopal Jayarama Reddy
Venugopal Jayarama Reddy
Shayanti MukherjeeShayanti Mukherjee
Shayanti Mukherjee
Seeram RamakrishnaSeeram Ramakrishna
Seeram Ramakrishna

5 November 2012 in Wound Repair and Regeneration
Verified
Journal Article
Closed access
PDF file
VRVenugopal Jayarama Reddy
Venugopal Jayarama Reddy
SRSRIDHAR RADHAKRISHNAN
SRIDHAR RADHAKRISHNAN
RRRajeswari Ravichandran
Rajeswari Ravichandran
Shayanti MukherjeeShayanti Mukherjee
Shayanti Mukherjee
RBRamalingam Balamurugan
Ramalingam Balamurugan
SRSeeram Ramakrishna
Seeram Ramakrishna